On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...